ALEXANDRIA, Va., July 8 -- Amicus Therapeutics, Philadelphia, Pennsylvania, has been assigned a patent (No. 11,376,244, initially filed Feb. 11, 2022) developed by two co-inventors for "methods of treating Fabry patients having renal impairment." The co-inventors are Jeff Castelli, New Hope, Pennsylvania, and Elfrida Benjamin, Millstone Township, New Jersey.

The full-text of the patent can be found at https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2 . . .